Andreas Tiede/ResearchGate
Dec 8, 2025, 11:08
Andreas Tiede: This Will Change Hematology Forever
Andreas Tiede, Professor, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, shared on LinkedIn:
”This will change Hematology forever: the milder Aza/Ven combination is more effective and less harmful than the traditional 3+7 chemo regimen in fit AML patients.
Groundbreaking data at ASH2025”
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from December 6 to 9.
It aims to bring together hematology professionals from across the globe.
Throughout the meeting, experts will present new research, clinical breakthroughs, and innovations that are defining the future of hematologic care.
More from ASH25 featured in Hemostasis Today.
-
Dec 8, 2025, 11:23Jorge Di Paola and Diane Krause Take Their Awards at ASH25
-
Dec 8, 2025, 09:39Asfand Yar Cheema Honored with Abstract Achievement Awards at ASH25
-
Dec 8, 2025, 09:27Ana Rita Rodrigues on the Impact of Post-Stroke Dysphagia
-
Dec 8, 2025, 09:19Sanam Loghavi and Shannon McWeeney at Joint Session on AI nad Hematology at ASH25
-
Dec 7, 2025, 18:43ASH25 Day 2: Don’t Miss The Highlights
-
Dec 7, 2025, 18:05Heghine Khachatryan Highlights a Patient-Friendly Breakthrough: Finger-Prick Micro-Sampling for Platelet Function
-
Dec 7, 2025, 17:01Abdul Mannan: How Do You Manage a Major Surgery When Blood Transfusion is Impossible?
-
Dec 7, 2025, 16:51Ahmed Bahi on Lina Merghani’s Critique of Early Withdrawal of Aspirin after PCI
-
Dec 7, 2025, 16:30Eloïse Laouenan Presents the Results of HEMOTHEPP-CHU Brest-GETBO Prospective Study